BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4890966)

  • 1. Skin-fold thickness in normal subjects and in patients with acromegaly and Cushing's syndrome.
    Wright AD; Joplin GF
    Acta Endocrinol (Copenh); 1969 Apr; 60(4):705-11. PubMed ID: 4890966
    [No Abstract]   [Full Text] [Related]  

  • 2. Bedside assessment of skin-fold thickness. A useful measurement for distinguishing Cushing's disease from other causes of hirsutism and oligomenorrhea.
    Corenblum B; Kwan T; Gee S; Wong NC
    Arch Intern Med; 1994 Apr; 154(7):777-81. PubMed ID: 8147682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin thickness in patients with acromegaly and Cushing's syndrome and response to treatment.
    Ferguson JK; Donald RA; Weston TS; Espiner EA
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):347-53. PubMed ID: 6872269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Cushing's syndrome and acromegaly.
    Br Med J; 1965 Aug; 2(5458):379-80. PubMed ID: 20718141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cushing's disease and acromegaly. Treatment of hormone active pituitary adenomas].
    Lüdecke DK; Flügge S; Carstens E
    Dtsch Krankenpflegez; 1992 Jan; 45(1):6-10. PubMed ID: 1737558
    [No Abstract]   [Full Text] [Related]  

  • 6. Deep-Learning Approach to Automatic Identification of Facial Anomalies in Endocrine Disorders.
    Wei R; Jiang C; Gao J; Xu P; Zhang D; Sun Z; Liu X; Deng K; Bao X; Sun G; Yao Y; Lu L; Zhu H; Wang R; Feng M
    Neuroendocrinology; 2020; 110(5):328-337. PubMed ID: 31319415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.
    Formenti AM; Maffezzoni F; Doga M; Mazziotti G; Giustina A
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):79-90. PubMed ID: 28477735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin thickness in endocrine disease. A roentgenographic study.
    Sheppard RH; Meema HE
    Ann Intern Med; 1967 Mar; 66(3):531-9. PubMed ID: 6019230
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical significance of the radioimmunological determination of plasma ACTH (author's transl)].
    Haydl H; Waldhäusl W
    Wien Klin Wochenschr; 1975 Jun; 87(13):401-6. PubMed ID: 180698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of endocrine disease from skin manifestations].
    Ishibashi M
    Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):986-94. PubMed ID: 9702007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of blood from the inferior sinus petrosus in patients with Cushing syndrome and acromegaly].
    Frey H; Torjesen PA; Enge IP; Stiris MG; Reinlie S
    Tidsskr Nor Laegeforen; 1994 Aug; 114(19):2257-61. PubMed ID: 7992292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Not Cushing's syndrome'.
    Rincón J; Greenblatt RB; Schwartz RP
    Am Fam Physician; 1979 May; 19(5):77-86. PubMed ID: 220864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic studies of the thymus in acromegaly, diabetes mellitus, and Cushing's syndrome.
    Souadjian JV; Molnar GD; Silverstein MN; Titus JL
    Metabolism; 1970 Jun; 19(6):401-5. PubMed ID: 5444243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison between the value of urinary free cortisol and 17-hydroxycorticosteroids for the diagnosis of Cushing's syndrome].
    Billon-Rey S; Beylot M; Mathian B; Patricot MC; Berthezene F; Mornex R; Revol A
    Presse Med; 1986 May; 15(21):965-8. PubMed ID: 2942852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft tissue measurements in acromegaly.
    Rake J; Snodgrass GJ; Nichols TR; Bayliss G
    Guys Hosp Rep; 1971; 120(2):161-6. PubMed ID: 5135011
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolic effects of adrenocorticotropic hormone in a patient with Cushing's syndrome and acromegaly.
    ELIEL LP; PEARSON OH
    J Clin Endocrinol Metab; 1951 Sep; 11(9):913-25. PubMed ID: 14873764
    [No Abstract]   [Full Text] [Related]  

  • 18. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of using basal plasma adrenocorticotropic hormone-radioimmunoassay (ACTH-RIA) level in the identification of the cause of Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 1997 Apr; 80(4):233-41. PubMed ID: 9175392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EXOPHTHALMOS-PRODUCING SUBSTANCE (EPS) FOUND IN PATIENTS WITH CUSHING'S SYNDROME AND ACROMEGALY].
    SCHWARZ F; DER KINDEREN PJ; HOUTSTRA-LANZ MH
    Ned Tijdschr Geneeskd; 1963 Oct; 107():2004-6. PubMed ID: 14053558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.